Clinical Performance Evaluation of the NeuMoDx™ FluA/FluB/RSV/Severe Acute Respiratory Syndrome-CoV-2 Assay

Clinical trial NCT05162547 · COMPLETED

Trial details

NCT number: NCT05162547
Sponsor: QIAGEN Gaithersburg, Inc
Status: COMPLETED
Study type: OBSERVATIONAL

Respiratory Disease

Start date: 2022-03-11
Primary completion: 2024-02-07
Enrollment: 2383

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.